Olfactory impairment in familial ataxias

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 10, 2012, Pages 970-974

  Moscovich, Mariana ^a,b,c   Munhoz, Renato Puppi ^a,c   Teive, Helio A ^a   Raskin, Salmo ^c   De Carvalho, Margarete J ^d   Barbosa, Egberto R ^d   Ranvaud, Ronald ^d   Liu, Jilin ^b   McFarland, Karen ^b   Ashizawa, Tetsuo ^b   Lees, Andrew J ^e   Silveira Moriyama, Laura ^e,f  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF FLORIDA   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HEREDITARY ATAXIA; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SCALE FOR THE ASSESSMENT AND RATES OF ATAXIA; SCORING SYSTEM; SMELLING DISORDER; SMOKING; SNIFFIN STICKS 16 SCORE; SPINOCEREBELLAR DEGENERATION;

ADULT; AGED; BRAZIL; CEREBELLAR ATAXIA; CEREBELLUM; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; OLFACTION DISORDERS; OLFACTORY PERCEPTION; PARKINSON DISEASE; SPINOCEREBELLAR ATAXIAS;

EID: 84866158136     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302770     Document Type: Article

References (45)

1. Ahlskog JE, Waring SC, Petersen RC, et al. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 1998;51:1672-7. (Pubitemid 28565251)
2. Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998;55:84-90. (Pubitemid 28139109)
3. Silveira-Moriyama L, Schwingenschuh P, O'Donnell A, et al. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 2009;80:744-8.
4. Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, et al. The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil. Mov Disord 2008;23:2328-34.
5. Silveira-Moriyama L, Guedes LC, Kingsbury A, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008;71:1021-6.
6. Silveira-Moriyama L, Hughes G, Church A, et al. Hyposmia in progressive supranuclear palsy. Mov Disord 2010;25:570-7.
7. Manto M, Marmolino D. Cerebellar ataxias. Curr Opin Neurol 2009;22:419-29.
8. Schols L, Bauer P, Schmidt T, et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304. (Pubitemid 38510200)
9. Klockgether T, Paulson H. Milestones in ataxia. Mov Disord 2011;26:1134-41.
10. Klockgether T. Update on degenerative ataxias. Curr Opin Neurol 2011;24:339-45.
11. Connelly T, Farmer JM, Lynch DR, et al. Olfactory dysfunction in degenerative ataxias. J Neurol Neurosurg Psychiatry 2003;74:1435-7.
12. Abele M, Riet A, Hummel T, et al. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol 2003;250:1453-5. (Pubitemid 38121842)
13. Fernandez-Ruiz J, Diaz R, Hall-Haro C, et al. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 2003;14:1339-41. (Pubitemid 36936721)
14. Braga-Neto P, Felicio AC, Pedroso JL, et al. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism Relat Disord 2011;17:353-6.
15. Yousem DM, Williams SC, Howard RO, et al. Functional MR imaging during odor stimulation: preliminary data. Radiology 1997;204:833-8. (Pubitemid 27369050)
16. Mainland JD, Johnson BN, Khan R, et al. Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. J Neurosci 2005;25:6362-71. (Pubitemid 40962531)
17. Teive HA, Munhoz RP, Raskin S, et al. Spinocerebellar ataxia type 10: frequency of epilepsy in a large sample of Brazilian patients. Mov Disord 2010;25:2875-8.
18. Teive HA, Munhoz RP, Arruda WO, et al. Spinocerebellar ataxia type 10-A review. Parkinsonism Relat Disord 2011;17:655-61.
19. Teive HA, Munhoz RP, Raskin S, et al. Spinocerebellar ataxia type 6 in Brazil. Arq Neuropsiquiatr 2008;66:691-4.
20. Kobal G, Hummel T, Sekinger B, et al. "Sniffin' sticks": screening of olfactory performance. Rhinology 1996;34:222-6.
21. Subramony SH. SARA - a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol 2007;3:136-7. (Pubitemid 46403939)
22. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-20. (Pubitemid 43964628)
23. Brucki SM, Nitrini R, Caramelli P, et al. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 2003;61:777-81. (Pubitemid 37236632)
24. Satya-Murti S, Crisostomo EA. Olfactory threshold in Friedreich's ataxia. Muscle Nerve 1988;11:406-7.
25. Velazquez-Perez L, Fernandez-Ruiz J, Diaz R, et al. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J Neurol 2006;253:1165-9. (Pubitemid 44511473)
26. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 2003;18:364-72. (Pubitemid 36527276)
27. Sobel N, Prabhakaran V, Hartley CA, et al. Odorant-induced and sniff-induced activation in the cerebellum of the human. J Neurosci 1998;18:8990-9001. (Pubitemid 28491763)
28. Qureshy A, Kawashima R, Imran MB, et al. Functional mapping of human brain in olfactory processing: a PET study. J Neurophysiol 2000;84:1656-66.
29. Savic I. Imaging of brain activation by odorants in humans. Curr Opin Neurobiol 2002;12:455-61. (Pubitemid 34876493)
30. Savic I. Brain imaging studies of the functional organization of human olfaction. Neuroscientist 2002;8:204-11. (Pubitemid 34538788)
31. Savic I, Gulyas B, Berglund H. Odorant differentiated pattern of cerebral activation: comparison of acetone and vanillin. Hum Brain Mapp 2002;17:17-27. (Pubitemid 34966793)
32. Savic I. Processing of odorous signals in humans. Brain Res Bull 2001;54:307-12. (Pubitemid 32279600)
33. Ferdon S, Murphy C. The cerebellum and olfaction in the aging brain: a functional magnetic resonance imaging study. Neuroimage 2003;20:12-21. (Pubitemid 37188495)
34. Burk K. Cognition in hereditary ataxia. Cerebellum 2007;6:280-6. (Pubitemid 47360064)
35. Molinari M, Chiricozzi FR, Clausi S, et al. Cerebellum and detection of sequences, from perception to cognition. Cerebellum 2008;7:611-15.
36. Tedesco AM, Chiricozzi FR, Clausi S, et al. The cerebellar cognitive profile. Brain 2011;134:3669-83.
37. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998;121:561-79. (Pubitemid 28162120)
38. Gottwald B, Mihajlovic Z, Wilde B, et al. Does the cerebellum contribute to specific aspects of attention? Neuropsychologia 2003;41:1452-60. (Pubitemid 36808818)
39. Chiricozzi FR, Clausi S, Molinari M, et al. Phonological short-term store impairment after cerebellar lesion: a single case study. Neuropsychologia 2008;46:1940-53.
40. Klein D, Milner B, Zatorre RJ, et al. The neural substrates underlying word generation: a bilingual functional-imaging study. Proc Natl Acad Sci U S A 1995;92:2899-903.
41. Peterburs J, Bellebaum C, Koch B, et al. Working memory and verbal fluency deficits following cerebellar lesions: relation to interindividual differences in patient variables. Cerebellum 2010;9:375-83.
42. Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 2009;44:489-501.
43. Timmann D, Brandauer B, Hermsdorfer J, et al. Lesion-symptom mapping of the human cerebellum. Cerebellum 2008;7:602-6.
44. Silveira-Moriyama L, Azevedo AM, Ranvaud R, et al. Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil. Arq Neuropsiquiatr 2010;68:700-5.
45. Morley JF, Weintraub D, Mamikonyan E, et al. Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord 2011;26:2051-7.